| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2008, p. 766-771, Vol. 46, No. 2
0095-1137/08/$08.00+0 doi:10.1128/JCM.01122-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
,
,
Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, Spain,1 Fungus Testing Laboratory, Department of Pathology, The University of Texas Health Science Center, San Antonio, Texas2
Received 5 June 2007/ Returned for modification 15 August 2007/ Accepted 4 December 2007
Based on the morphological, physiologic, and molecular (β-tubulin gene) study of 141 isolates of the Pseudallescheria boydii species complex (including several synonyms) and relatives, the new species Scedosporium dehoogii is proposed. Scedosporium apiospermum and P. boydii are considered two different species and the new name Scedosporium boydii is proposed for the anamorph of the latter species. A summary of the key morphological and physiological features for distinguishing the species of Pseudallescheria/Scedosporium is provided.
Published ahead of print on 12 December 2007.
Supplemental material for this article may be found at http://jcm.asm.org/.
Communication of the ECMM Working Group on Pseudallescheria and Scedosporium.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|